US SB4905 | 2023-2024 | 118th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on July 31 2024 - 25% progression, died in committee
Action: 2024-07-31 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S5685-5686)
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on July 31 2024 - 25% progression, died in committee
Action: 2024-07-31 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S5685-5686)
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Summary
A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to molecularly targeted pediatric cancer investigations, and for other purposes.
Title
Innovation in Pediatric Drugs Act of 2024
Sponsors
| Sen. Jack Reed [D-RI] | Sen. Shelley Capito [R-WV] |
History
| Date | Chamber | Action |
|---|---|---|
| 2024-07-31 | Senate | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S5685-5686) |
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/118th-congress/senate-bill/4905/all-info |
| Text | https://www.congress.gov/118/bills/s4905/BILLS-118s4905is.pdf |
